Icatibant Xiromed, sol inj 30 mg/3ml , ser pré 3 ml

7680682630011 CH-68263 B06AC02
Icatibant Xiromed, sol inj 30 mg/3ml , ser pré 3 ml
Icatibant Xiromed, sol inj 30 mg/3ml , ser pré 3 ml
Icatibant Xiromed, sol inj 30 mg/3ml , ser pré 3 ml
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/06/2026
Patient information leaflet
Français
17/06/2026
Patient information leaflet
Italien
17/06/2026
Professional SmPC
Allemand
17/06/2026
Professional SmPC
Français
17/06/2026
Professional SmPC
Italien
17/06/2026

Detailed composition

Substance Quantity Type Category
icatibantum
30.0 MG Substance Wirkstoff (Principe actif)
icatibanti acetas
- Substance WIZUS
natrii chloridum
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
9.9 MG Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68263
Drug name
Icatibant Spirig HC 30 mg, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
B06AC02
Authorization status
Z
Dispensation category
B
First authorization
17/02/2022
Authorization expiration date
31/12/9999
IT number
02.99.0.
Domain
Human medicine
Field of application
Behandlung von Angioödem (Treatment of Angioedema)

Packaging details

Description (FR)
ICATIBANT Xiromed sol inj 30 mg/3ml ser pré 3 ml
Description (DE)
ICATIBANT Xiromed Inj Lös 30 mg/3ml Fertspr 3 ml
Narcotic (BTM)
No

Available generics

Icatibant Spirig HC 30 mg, Injektionslösung in einer Fertigspritze
CHF 806.15
View

Other packaging sizes

ICATIBANT Spirig HC 30 mg / 30 mg / 1 x 3 ml
1 x 3 ML
View
Buy us a coffee Explore the data